Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2008-04-15 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: NICE (06000), Alpes-Maritimes
PHARMACIE NOTRE DAME : revenue, balance sheet and financial ratios
PHARMACIE NOTRE DAME is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in NICE (06000),
this company of category PME
shows in 2022 a revenue of 1.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE NOTRE DAME (SIREN 504487364)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
1 468 923 €
N/C
N/C
N/C
N/C
N/C
1 074 147 €
Net income
59 820 €
40 631 €
95 651 €
59 920 €
79 836 €
101 150 €
76 828 €
48 402 €
-18 816 €
EBITDA
N/C
N/C
145 969 €
N/C
N/C
N/C
N/C
N/C
74 280 €
Net margin
N/C
N/C
6.5%
N/C
N/C
N/C
N/C
N/C
-1.8%
Revenue and income statement
In 2024, PHARMACIE NOTRE DAME generates positive net income of 60 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
59 820 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 50%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 59%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
49.929%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
59.291%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
526.912
377.866
253.936
167.223
140.494
109.928
78.179
68.337
49.929
Financial autonomy
14.372
18.986
25.595
33.273
37.298
42.764
50.035
53.552
59.291
Repayment capacity
20.564
None
None
None
None
None
4.642
None
None
Cash flow / Revenue
4.196%
None%
None%
None%
None%
None%
7.269%
None%
None%
Sector positioning
Debt ratio
49.932024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Good-6 pts over 3 years
In 2024, the debt ratio of PHARMACIE NOTRE DAME (49.93) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
59.29%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Good+8 pts over 3 years
In 2024, the financial autonomy of PHARMACIE NOTRE DAME (59.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
4.64 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE NOTRE DAME (4.64) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 105.75. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
125.1
109.183
107.52
118.998
142.972
137.692
150.555
125.936
105.753
Interest coverage
39.313
None
None
None
None
None
8.879
None
None
Sector positioning
Liquidity ratio
105.752024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Watch-6 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE NOTRE DAME (105.75) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
8.88x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Excellent
In 2022, the interest coverage of PHARMACIE NOTRE DAME (8.9x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE NOTRE DAME
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
78 112 €
0 €
0 €
0 €
0 €
0 €
88 576 €
0 €
0 €
Inventory turnover (days)
31
0
0
0
0
0
29
0
0
Customer payment term (days)
3
54
35
52
42
78
2
0
0
Supplier payment term (days)
41
799
761
931
880
740
32
0
0
Positioning of PHARMACIE NOTRE DAME in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE NOTRE DAME is estimated at
835 131 €
(range 581 572€ - 1 249 404€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
581k€835k€1249k€
835 131 €Range: 581 572€ - 1 249 404€
NAF 5 année 2024
Valuation method used
Net Income Multiple
59 820 €
×
14.0x
=835 131 €
Range: 581 572€ - 1 249 404€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE NOTRE DAME with other companies in the same sector:
Frequently asked questions about PHARMACIE NOTRE DAME
What is the revenue of PHARMACIE NOTRE DAME ?
The revenue of PHARMACIE NOTRE DAME in 2022 is 1.5 M€.
Is PHARMACIE NOTRE DAME profitable?
Yes, PHARMACIE NOTRE DAME generated a net profit of 60 k€ in 2024.
Where is the headquarters of PHARMACIE NOTRE DAME ?
The headquarters of PHARMACIE NOTRE DAME is located in NICE (06000), in the department Alpes-Maritimes.
Where to find the tax return of PHARMACIE NOTRE DAME ?
The tax return of PHARMACIE NOTRE DAME is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE NOTRE DAME operate?
PHARMACIE NOTRE DAME operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart